Germline mutations in BRCA1/BRCA2 lead to a hereditary cancer predisposition syndrome that can increase the risk of ovarian, breast, prostate, and pancreatic cancer, among others [1–3]. This evidence concerns the gene BRCA1 and familial pancreatic carcinoma.